Xellia ApS
| File:Xellia logo.jpg | |
| Aktieselskab | |
| ISIN | 🆔 |
| Industry | Pharmaceuticals, health care |
| Founded 📆 | 1958 |
| Founder 👔 | |
| Headquarters 🏙️ | Copenhagen, Denmark |
Area served 🗺️ | |
Key people | Carl-Åke Carlsson (CEO)[1] |
| Products 📟 | Bacitracin, Colistimethate, Daptomycin, Polymyxin B, Vancomycin[2] |
| Revenue🤑 |  $317.1 million (2018[3][4][5][6][7][8] |
| Members | |
Number of employees | 1,500 (2018)[3] |
| Parent | Novo Nordisk |
| 🌐 Website | [1] |
| 📇 Address | |
| 📞 telephone | |
Xellia ApS is a Danish multinational pharmaceutical and life sciences company headquartered in Copenhagen.[9][10] Xellia specializes in the production of anti-infective agents. The company is a subsidiary of Novo Nordisk.[11][12]
History
Xellia is an outgrowth of Apothekernes Laboratorium, which was founded in Norway in 1903.[13][14] Apothekernes Laboratorium began production of Bacitracin in 1954 in Oslo.[13] In 1975 Apothekernes Laboratory established A.L. Laboratories Inc. in the United States. A.L. Laboratories grew to be the largest producer of Bacitracin in the United States, and was listed on the New York Stock Exchange in 1989.[13]
In 1994, A.L. Laboratories, Dumex, and Apothekernes Laboratorium merged to form Alpharma.[13]
Alpharma was acquired by 3i in 2008 and rebranded as Xellia.[13]
Xellia was then acquired by Novo Holdings A/S in 2013.[15]
Products
Xellia's focus is on anti-infectives, including antibiotics, antivirals, and antifungals.
Their longest standing offering, Bacitracin, is used both in pharmaceutical and veterinary applications.[13]
See also
References
- ↑ "Bloomberg Private Company Information: Xellia". Bloomberg. Retrieved 22 October 2018.
- ↑ "Xellia Products | Xellia Product Catalog".
- ↑ 3.0 3.1 "Novo Nordisk Acquires Xellia". Business Wire. 2018-03-21. Retrieved 29 October 2018.
- ↑ https://www.crunchbase.com/acquisition/novonordisk-acquires-xellia-pharmaceuticals--343a208b
- ↑ http://www.pharmtech.com/novo-acquires-xellia-us-700-million
- ↑ "Novo buys Norway's Xellia for $700 million". 2013-05-21.
- ↑ "Novo A/S acquires Xellia Pharma Pharmaceuticals - Nordic Life Science". 2013-05-24.
- ↑ "Novo holding company buys Norwegian Xellia". Reuters. 2013-05-21.
- ↑ "Public Assessment Report, Decentralised Procedure" (PDF). mhra.gov.uk. Medicines and Healthcare products Regulatory Agency, Government of the United Kingdom.
- ↑ "Xellia Buys Fresenius Kabi's Raleigh Drug Plant". ncbiotech.org. North Carolina Biotechnology Center.
- ↑ "Novo holding company buys Norwegian Xellia". Reuters. 2013-05-21.
- ↑ https://www.crunchbase.com/acquisition/novonordisk-acquires-xellia-pharmaceuticals--343a208b
- ↑ 13.0 13.1 13.2 13.3 13.4 13.5 "Our Heritage | Xellia Pharmaceuticals".
- ↑ "Google Translate".
- ↑ "3i makes a 2.3x return on the sale of Xellia".
Category:Danish brands Category:Life sciences industry
Category:Biotechnology companies of Denmark Category:Danish brands Category:Life sciences industry Category:Multinational companies headquartered in Denmark
This article "Xellia" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Xellia. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
|
This page exists already on Wikipedia. |
